全文获取类型
| 收费全文 | 11397篇 |
| 免费 | 633篇 |
| 国内免费 | 29篇 |
专业分类
| 耳鼻咽喉 | 69篇 |
| 儿科学 | 295篇 |
| 妇产科学 | 221篇 |
| 基础医学 | 1800篇 |
| 口腔科学 | 110篇 |
| 临床医学 | 1086篇 |
| 内科学 | 2489篇 |
| 皮肤病学 | 285篇 |
| 神经病学 | 1065篇 |
| 特种医学 | 545篇 |
| 外国民族医学 | 3篇 |
| 外科学 | 1409篇 |
| 综合类 | 56篇 |
| 一般理论 | 1篇 |
| 预防医学 | 862篇 |
| 眼科学 | 154篇 |
| 药学 | 708篇 |
| 中国医学 | 32篇 |
| 肿瘤学 | 869篇 |
出版年
| 2023年 | 48篇 |
| 2022年 | 52篇 |
| 2021年 | 186篇 |
| 2020年 | 111篇 |
| 2019年 | 211篇 |
| 2018年 | 413篇 |
| 2017年 | 243篇 |
| 2016年 | 287篇 |
| 2015年 | 321篇 |
| 2014年 | 402篇 |
| 2013年 | 490篇 |
| 2012年 | 909篇 |
| 2011年 | 898篇 |
| 2010年 | 437篇 |
| 2009年 | 407篇 |
| 2008年 | 744篇 |
| 2007年 | 812篇 |
| 2006年 | 742篇 |
| 2005年 | 757篇 |
| 2004年 | 672篇 |
| 2003年 | 656篇 |
| 2002年 | 519篇 |
| 2001年 | 131篇 |
| 2000年 | 147篇 |
| 1999年 | 93篇 |
| 1998年 | 62篇 |
| 1997年 | 35篇 |
| 1996年 | 32篇 |
| 1995年 | 25篇 |
| 1994年 | 31篇 |
| 1993年 | 46篇 |
| 1992年 | 46篇 |
| 1991年 | 46篇 |
| 1990年 | 56篇 |
| 1989年 | 56篇 |
| 1988年 | 65篇 |
| 1987年 | 54篇 |
| 1986年 | 73篇 |
| 1985年 | 65篇 |
| 1984年 | 53篇 |
| 1983年 | 34篇 |
| 1981年 | 38篇 |
| 1980年 | 29篇 |
| 1979年 | 29篇 |
| 1978年 | 35篇 |
| 1976年 | 29篇 |
| 1973年 | 31篇 |
| 1971年 | 23篇 |
| 1969年 | 29篇 |
| 1968年 | 25篇 |
排序方式： 共有10000条查询结果，搜索用时 0 毫秒
1.
2.
Hajrunisa Cubro Karl A. Nath Sonja Suvakov Oscar Garcia-Valencia Santosh Parashuram Wendy M. White Tracey L. Weissgerber Meryl C. Nath Natasa M. Milic Fernando Sontag Livius V. d’Uscio Yi Zhu James L. Kirkland Tamar Tchkonia Mariam P. Alexander Reade A. Quinton Zvonimir S. Katusic Joseph P. Grande Vesna D. Garovic 《Kidney international》2021,99(3):646-656
- Download : Download high-res image (380KB)
- Download : Download full-size image
3.
Le Bot Audrey Sokal Aurélien Choquet Anaïs Maire Frédérique Fantin Bruno Sauvanet Alain de Lastours Victoire 《European journal of clinical microbiology & infectious diseases》2022,41(8):1139-1143
European Journal of Clinical Microbiology & Infectious Diseases - Twenty-five patients with reflux cholangitis (RC) defined as acute cholangitis (AC) with normal abdominal imaging... 相似文献
4.
Marta López-Fauqued Laura Campora Frédérique Delannois Mohamed El Idrissi Lidia Oostvogels Ferdinandus J. De Looze Javier Diez-Domingo Thomas C. Heineman Himal Lal Janet E. McElhaney Shelly A. McNeil Wilfred Yeo Fernanda Tavares-Da-Silva 《Vaccine》2019,37(18):2482-2493
Background
The ZOE-50 (NCT01165177) and ZOE-70 (NCT01165229) phase 3 clinical trials showed that the adjuvanted recombinant zoster vaccine (RZV) was ≥90% efficacious in preventing herpes zoster in adults. Here we present a comprehensive overview of the safety data from these studies.Methods
Adults aged ≥50 (ZOE-50) and ≥70 (ZOE-70) years were randomly vaccinated with RZV or placebo. Safety analyses were performed on the pooled total vaccinated cohort, consisting of participants receiving at least one dose of RZV or placebo. Solicited and unsolicited adverse events (AEs) were collected for 7 and 30?days after each vaccination, respectively. Serious AEs (SAEs) were collected from the first vaccination until 12?months post-last dose. Fatal AEs, vaccination-related SAEs, and potential immune-mediated diseases (pIMDs) were collected during the entire study period.Results
Safety was evaluated in 14,645 RZV and 14,660 placebo recipients. More RZV than placebo recipients reported unsolicited AEs (50.5% versus 32.0%); the difference was driven by transient injection site and solicited systemic reactions that were generally seen in the first week post-vaccination. The occurrence of overall SAEs (RZV: 10.1%; Placebo: 10.4%), fatal AEs (RZV: 4.3%; Placebo: 4.6%), and pIMDs (RZV: 1.2%; Placebo: 1.4%) was balanced between groups. The occurrence of possible exacerbations of pIMDs was rare and similar between groups. Overall, except for the expected local and systemic symptoms, the safety results were comparable between the RZV and Placebo groups irrespective of participant age, gender, or race.Conclusions
No safety concerns arose, supporting the favorable benefit-risk profile of RZV. 相似文献5.
6.
Donna M. Brennan-Crispi Andrew M. Overmiller Lukas Tamayo-Orrego Molly R. Marous Joya Sahu Kathleen P. McGuinn Felicia Cooper Ioanna Ch. Georgiou Maxwell Frankfurter Julio C. Salas-Alanis Frédéric Charron Sarah E. Millar Mỹ G. Mahoney Natalia A. Riobo-Del Galdo 《The Journal of investigative dermatology》2019,139(2):300-307
7.
Frédéric Janvier Deborah Delaune Thomas Poyot Eric Valade Audrey Mérens Pierre E. Rollin Vincent Foissaud 《Emerging infectious diseases》2016,22(2):292-294
We evaluated RNA stability of Ebola virus in EDTA blood and urine samples collected from infected patients and stored in West Africa’s environmental conditions. In blood, RNA was stable for at least 18 days when initial cycle threshold values were <30, but in urine, RNA degradation occurred more quickly. 相似文献
8.
Jeremiah J. Faith Jean-Frédéric Colombel Jeffrey I. Gordon 《Proceedings of the National Academy of Sciences of the United States of America》2015,112(3):633-640
It has been 35 y since Carl Woese reported in PNAS how sequencing ribosomal RNA genes could be used to distinguish the three domains of life on Earth. During the past decade, 16S rDNA sequencing has enabled the now frequent enumeration of bacterial communities that populate the bodies of humans representing different ages, cultural traditions, and health states. A challenge going forward is to quantify the contributions of community members to wellness, disease risk, and disease pathogenesis. Here, we explore a theoretical framework for studies of the inheritance of bacterial strains and discuss the advantages and disadvantages of various study designs for assessing the contribution of strains to complex diseases. 相似文献
9.
10.